Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs-Updated Review

• Published in: Biomedicines 2023-03, Vol.11 (3), p.952
• Main Authors: Mruk-Mazurkiewicz, Honorata, Kulaszyńska, Monika, Jakubczyk, Karolina, Janda-Milczarek, Katarzyna, Czarnecka, Wiktoria, Rębacz-Maron, Ewa, Zacha, Sławomir, Sieńko, Jerzy, Zeair, Samir, Dalewski, Bartosz, Marlicz, Wojciech, Łoniewski, Igor, Skonieczna-Żydecka, Karolina
• Format: Article
• Language: English
• Subjects: Anti-inflammatory agents; Antibiotics; Bacteria; Cancer therapies; Diabetes; Digestive system; Drug therapy; Drugs; E coli; Fatty acids; Gastroenterology; Gastrointestinal tract; Glucose; Health aspects; Inflammation; Insulin; interactions; Intestinal microflora; Metabolic disorders; Metabolites; Microbiota; Microbiota (Symbiotic organisms); Microorganisms; Pharmaceuticals; Pharmacodynamics; Pharmacokinetics; pharmacotherapy; phytochemicals; Psychotropic drugs; Review
• ISSN: 2227-9059; 2227-9059
• DOI: 10.3390/biomedicines11030952

As pharmacology and science progress, we discover new generations of medicines. This relationship is a response to the increasing demand for medicaments and is powered by progress in medicine and research about the respective entities. However, we have questions about the efficiency of pharmacotherapy in individual groups of patients. The effectiveness of therapy is controlled by many variables, such as genetic predisposition, age, sex and diet. Therefore, we must also pay attention to the microbiota, which fulfill a lot of functions in the human body. Drugs used in psychiatry, gastroenterology, diabetology and other fields of medicine have been demonstrated to possess much potential to change the composition and probably the function of the intestinal microbiota, which consequently creates long-term risks of developing chronic diseases. The article describes the amazing interactions between gut microbes and drugs currently used in healthcare.